Clinical Trial Update: Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy for Chronic Ischemic Left Ventricular Dysfunction [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating human embryonic stem cell-derived cardiomyocytes for chronic ischemic left ventricular dysfunction; recruitment is currently o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Left Ventricular Dysfunction

Drugs mentioned

• Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy

Snippet

Sponsor: Joseph C. Wu | Conditions: Chronic Ischemic Left Ventricular Dysfunction | Phase 1 | Status: RECRUITING